Cenobamate is an effective treatment for drug resistance focal epilepsy: a critical review
Cenobamate, recently approved anticonvulsant by the Food and Drug Administration (FDA), stands as a potential remedy for drug-resistant epilepsy (DRE). It shows promise in enhancing seizure management efficacy. An in-depth analysis of various literature sources, encompassing clinical trials, preclin...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | MGM Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.mgmjms.com/article.asp?issn=2347-7946;year=2023;volume=10;issue=4;spage=783;epage=788;aulast=Hiremath |